Legal & General Group’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Sell
13,169
-1,614
-11% -$362K ﹤0.01% 1746
2025
Q4
$3.15M Buy
14,783
+13,359
+938% +$2.76M ﹤0.01% 1796
2025
Q3
$283K Buy
1,424
+1,119
+367% +$209K ﹤0.01% 2561
2025
Q2
$52.6K Sell
305
-472
-61% -$76.9K ﹤0.01% 2704
2025
Q1
$121K Sell
777
-16,905
-96% -$2.41M ﹤0.01% 2653
2024
Q4
$2.43M Buy
17,682
+16,628
+1,578% +$2.19M ﹤0.01% 1892
2024
Q3
$157K Hold
1,054
﹤0.01% 2700
2024
Q2
$144K Buy
1,054
+189
+22% +$25.7K ﹤0.01% 2704
2024
Q1
$131K Buy
865
+667
+337% +$95.2K ﹤0.01% 2721
2023
Q4
$24.9K Sell
198
-840
-81% -$83.7K ﹤0.01% 2947
2023
Q3
$97.2K Buy
+1,038
New +$97.1K ﹤0.01% 2831

Other funds holding ASND